Results 131 to 140 of about 1,869,033 (226)

Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9633-9643, October 2026.
ABSTRACT Aims Evidence regarding the efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in monogenic diabetes is limited. We evaluated real‐world metabolic, renal, and safety outcomes of SGLT2i therapy in adults with monogenic diabetes.
Estelle Audrain, Pierre Bel Lassen, Christine Bellanné‐Chantelot, Marie Christine Vantyghem, Hippolyte Dupuis, Tiphaine Vidal‐Trecan, Nicolas Chevalier, Danièle Dubois‐Laforgue, Sophie Lamothe, Camille Vatier, Orianne Villard, René Valéro, Claire Briet, Corinne Vigouroux, Cécile Ciangura, Chloé Amouyal   +15 more
wiley   +1 more source

A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspective

Frontiers in Cardiovascular Medicine
Cardio-kidney metabolic (CKM) syndrome represents a complex and circular interplay of cardiovascular, renal, and metabolic dysfunctions, significantly contributing to global morbidity and mortality.
Massimo Iacoviello, Mauro Gori, Giuseppe Grandaliano, Giuseppe Grandaliano, Roberto Minutolo, Dario Pitocco, Roberto Trevisan, Roberto Trevisan   +7 more
doaj   +1 more source

Cardio-renal interrelation: modern view

The paper discusses the definition and classification of cardio-renal syndrome (CRS) - a pathological process in heart or kidneys, characterised by acute or chronic dysfunction of one organ which results in acute or chronic failure of the other organ ...
Villewalde S.V., Moiseev V.S., Efremovtseva M.A., Kobalava Z.D.   +3 more
core  

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovascular Diabetology
Background Cardio-Kidney-Metabolic (CKM) syndrome results from the complex interaction of cardiovascular, renal and metabolic comorbidities. Data on the epidemiology and clinical impact of the CKM syndrome in patients with atrial fibrillation (AF) are ...
Giulio Francesco Romiti, Davide Antonio Mei, Bernadette Corica, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Tze-Fan Chao, Menno V. Huisman, Gregory Y. H. Lip, the GLORIA-AF Investigators   +9 more
doaj   +1 more source

The cardio-renal effect of pea protein hydrolysate in a chronic kidney disease rat model [PDF]

, 2012
Pea protein hydrolysate (PPH) has antihypertensive effects and prostanoids have been implicated in renal diseases. To investigate the role of PPH and prostanoids on renal and cardiovascular effects in cardio-renal disease, normal and diseased Han:SPRD ...
Prairie, Natalie Paula
core  

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part III) on Rate and Rhythm Control in Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Minglong Chen, Kyoko Soejima, Melanie Gunawardene, Pipin Kojodjojo, Hailei Liu, Tong Liu, Shinsuke Miyazaki, Itsuro Morishima, Prashanthan Sanders, Hung Fat Tse, Takanori Yamaguchi, Eue‐Keun Choi, Boyoung Joung, Rungroj Krittayaphong, Melissa Middeldorp, Gregory Y. H. Lip, Hui‐Nam Pak, Tze‐Fan Chao, Young‐Hoon Kim, Shih‐Ann Chen   +19 more
wiley   +1 more source

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection

Clinical Interventions in Aging, 2013
Darko Duplancic,1 Marijan Cesarik,2 Nikola Kolja Poljak,3 Maja Radman,4 Vedran Kovacic,5 Josipa Radic,5 Veljko Rogosic61Department of Cardiology, School of Medicine in Split, University Hospital Split, Split, Croatia; 2Department for Neurology, County ...
Duplancic D, Cesarik M, Poljak NK, Radman M, Kovacic V, Radic J, Rogosic V   +6 more
doaj  

[Cardio-renal syndrome: pathophysiology and treatment].

Revista da Associacao Medica Brasileira (1992), 2009
Chronic kidney disease (CKD) is one of the most important problems of public health, worldwide. Anemia is frequent in CKD, affecting approximately 90% of patients. The relationship between anemia and cardiovascular disease is well established and is due to alterations in left ventricular structure and function.
Samuel de Paula, Miranda, Rafael Nogueira de, Macedo, Geraldo Bezerra da, Silva Júnior, Elizabeth De Francesco, Daher   +3 more
openaire   +1 more source

The impact of cardio-renal-metabolic profile in dilated cardiomyopathy

Purpose of Review Dilated cardiomyopathy is an important contributor to heart failure burden worldwide. With an aging population and rising multimorbidity, in this review, we describe the prevalence of metabolic syndrome and renal failure in patients ...
Prasad, Sanjay K, Hammersley, Daniel J, Akbari, Tamim, Halliday, Brian P, May, Clarice Yau-Yee   +4 more
core   +1 more source

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease

Diabetology & Metabolic Syndrome
Background Metabolic Syndrome—a constellation of insulin resistance, cardiovascular risk factors as hyperglycemia, hypertension, and dyslipidemia, and systemic metabolic dysfunction—may be driven by dysregulation of adipose tissue, which manifests as ...
Amélio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto, Andrei C. Sposito, José Hermógenes Rocco Suassuna   +5 more
doaj   +1 more source